[1]WHO Guidelines Approved by the Guidelines Review committee. Global Tuberculosis Report\[R\]. Geneva:World Health Organization, 2019.
[2]Donovan J, Figaji A, Imran D, et al. The neurocritical care of tuberculous meningitis\[J\]. Lancet Neurol, 2019, 18(8): 771-783.
[3]崔会娟,何俊瑛.脑脊液检测诊断结核性脑膜炎\[J\].河北医科大学学报,2006,27(5):498-500.
[4]Wang YY, Xie BD. Wang YY, et al. Progress on diagnosis of Tuberculous meningitis\[J\]. Methods Mol Biol, 2018, 1754: 375-386.
[5]Mécha F, Bouchaud O. Tuberculous meningitis: challenges in diagnosis and management\[J\]. Rev Neurol (Paris), 2019, 175(7-8): 451-457.
[6]刘亚娟,何俊瑛,卜晖,等.改良抗酸染色阳性的170例结核性脑膜炎脑脊液分析\[J\].中国神经精神疾病杂志,2017,43(4):215-219.
[7]金慧芳,刘鑫.脑脊液Gene Xpert MTB/RIF检测和结核杆菌快速培养辅助诊断结核性脑膜炎的价值比较\[J\].临床内科杂志,2018,35(8):529-530.
[8]Wilson SM, alSuwaidi Z, McNerney R, et al. Evaluation of a new rapid bacteriophagebased method for the drug susceptibility testing of Mycobacterium tuberculosis\[J\].Nat Med, 1997, 3(4): 465-468.
[9]Kalantri SP, Pai M, Pascopella L, et al. Bacteriophagebased tests for the detection of Mycobacterium tuberculosis in clinical specimens: A systematic review and metaanalysis\[J\]. BMC Infect Dis, 2005,5:59.
[10]冯爽,刘树业,张立,等.噬菌体生物扩增法与常规方法在结核分枝杆菌检测中的比较\[J\].实用预防医学,2011,18(5):920-922.
[11]高建超,柳晓金,齐海亮,等.噬菌体生物扩增法与常规方法对结核性脑膜炎诊断意义对比分析\[J\].现代预防医学,2014,41(22):4112-4113,4123.
[12]Caviedes L, Lee TS, Gilman RH, et al. Rapid efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru \[J\]. J Clin Microbiol, 2000,38(3):1203-1208.
[13]付佑辉,张舒,王海涛,等.显微镜观察药物敏感性技术快速检测痰标本中结核分枝杆菌的研究\[J\].国际检验医学杂志,2016,37(6):728-730.
[14]杨丽霞,胡国信,方铭,等.显微镜观察药物敏感性检测技术在结核性脑膜炎诊断及其耐药性检测中的应用\[J\].江西医药,2012,47(6):488-491.
[15]Tuon FF, Higashino HR, Lopes MI, et al. Adenosine deaminase and tuberculous meningitis—a systematic review with metaanalysis\[J\]. Scand J Infect Dis, 2010,42(3):198-207.
[16]Jai PB, Rakhee Y. Diagnostic significance of adenosine deaminase in cerebrospinal fluid and blood of tubercular meningitis patients\[J\]. IJBAMR, 2015, 4(4): 208-214.
[17]李雪莲,马丽萍,陈红梅,等.脑脊液中腺苷脱氨酶水平对结核性脑膜炎的诊断价值\[J\].中华结核和呼吸杂志,2017,40(5):339-342.
[18]Pormohammad A, Riahi SM, Nasiri MJ, et al. Diagnostic test accuracy of adenosine deaminase for tuberculous meningitis: A systematic review and metaanalysis\[J\]. J Infect, 2017, 74(6): 545-554.
[19]Sakai S, MayerBarber KD, Barber DL. Defining features of protective CD4 T cell responses to Mycobacterium tuberculosis\[J\]. Curr Opin Immunol, 2014, 29:137-142.
[20]Belknap R, Daley CL. Interferonγ release assays\[J\]. Clin Lab Med, 2014, 34(2):337-349.
[21]Yu J, Wang ZJ, Chen LH, et al. Diagnostic accuracy of interferonγ release assays for tuberculous meningitis: a metaanalysis\[J\]. Int J Tuberc Lung Dis, 2016, 20(4):494-499.
[22]石利民, 王燕, 崔红莲, 等. Epidot酶联免疫斑点检测方法应用于结核诊断的初步评价\[J\].江苏大学学报(医学版),2012,22(5):444-447,451.
[23]崔中锋,刘春礼,李格,等.TSPOT.TB在结核性脑膜炎早期诊断中的价值\[J\].中国实用神经疾病杂志, 2016, 19(16): 97-98.
[24]李雪莲,陈红梅,张立群,等.脑脊液γ干扰素检测对结核性脑膜炎的诊断价值\[J\].中国医刊, 2016,51(11):35-38.
[25]Ling DI, Flores LL, Riley LW, et al. Commercial nucleicacid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: metaanalysis and metaregression\[J\]. PLoS One, 2008, 3(2): e1536.
[26]Palomo FS, Rivero MGC, Quiles MG, et al. Comparison of DNA extraction protocols and molecular targets to diagnose tuberculous meningitis\[J\]. Tuberc Res Treat, 2017, 2017: 5089046.
[27]Gupta R, Talwar P, Talwar P, et al. Diagnostic accuracy of nucleic acid amplification based assays for tuberculous meningitis: A metaanalysis\[J\]. J Infect, 2018, 77(4): 302-313.
[28]邵雪君,朱宏,牛莉莉,等.巢式荧光PCR结合高分辨熔链曲线检测结核分枝杆菌及其亚型\[J\].江苏大学学报(医学版), 2015,25(4): 342-345.
[29]WHO Guidelines Approved by the Guidelines Review committee. Automated realtime nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance:Xpert MTB/RIF assay for the diagnosis of pulnlonary and extrapulnlonary TB in adults and children:policy update\[R\]. Geneva: World Health Organization, 2013.
[30]Bahr NC, Tugume L, Rajasingham R, et al. Improved diagnostic sensitivity for tuberculous meningitis with Xpert MTB/RIF of centrifuged CSF\[J\]. Int J Tuberc Lung Dis, 2015, 19(10): 1209-1215.
[31]范秀博,闫菊娥,李毓新,等. Xpert Mtb/RIF技术在结核性脑膜炎诊断中的应用\[J\].山东医药,2017,57(43):61-63.
[32]Opota O, MazzaStalder J, Greub G, et al. The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection\[J\]. Clin Microbiol Infect, 2019, 25(11): 1370-1376.
[33]Bahr NC, Nuwagira E, Evans EE, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIVinfected adults: a prospective cohort study\[J\]. Lancet Infect Dis, 2018, 18(1): 68-75.
[34]张培泽,郑俊峰,付亮,等.Xpert MTB/RIF Ultra诊断结核性脑膜炎的价值\[J\].结核病与肺部健康杂志,2019,8(1):42-47.
[35]Marais S, Thwaites G, Schoeman JF, et al. Tuberculous meningitis: a uniform case defi nition for use in clinical research\[J\]. Lancet Infect Dis, 2010, 10(11): 803-812.
[36]Schaller MA, Wicke F, Foerch C, et al. Central nervous system Tuberculosis: etiology, clinical manifestations and neuroradiological features\[J\]. Clin Neuroradiol, 2019, 29(1): 3-18.
[37]马燕粉,李英,武倩,等.影像学及实验室检查在结核性脑膜炎早期诊断中的应用研究\[J\]. 国际检验医学杂志,2017,38(4):444-446.
[38]赵露,姜文雯,张馨,等.结核性脑膜炎MRI脑膜病变形态和信号特点及颅内继发性改变特征分析\[J\].脑与神经疾病杂志,2019,27(1):33-37.
[39]Solari L, Soto A, Van der Stuyft P. Development of a clinical prediction rule for tuberculous meningitis in adults in Lima, Peru\[J\]. Trop Med Int Health, 2018, 23(4): 367-374.
[40]Chusri S, Hortiwakul T, Sathaporn N, et al.Diagnostic scoring system for tuberculous meningitis among adult patients with nonsuppurative and nonbacterial meningitis\[J\]. J Infect Chemother, 2018, 24(8): 648-653.
|